About VisioPro
Overview
VisioPro® is a high-potency probiotic brand dedicated to digestive and intestinal health. The brand markets products containing the De Simone Formulation, a proprietary combination of eight strains of live lactic-acid bacteria and bifidobacteria. In Singapore, VisioPro is associated with Hyphens Pharma International Limited, which identifies it as a proprietary brand that was rebranded from Vivomixx® in March 2025 1.
The brand positions itself around maintaining and restoring the balance of the intestinal microbiota. Its product range is designed for various demographic groups, including adults, children, and women. Distribution channels include pharmacies, clinics, and online retail.
Quick Facts
| Field | Information |
|---|---|
| Brand | VisioPro® |
| Category | Probiotic / dietary supplement |
| Main focus | Gut, digestive and intestinal health |
| Previous brand name | Vivomixx® |
| Rebrand | 2025 |
| Key formulation | De Simone Formulation |
| Number of strains | 8 |
| Main markets/products | Adult, Kids, Women, Plus, Drops |
| Standard capsule potency | 112.5 billion live bacteria |
| Standard sachet potency | 450 billion live bacteria |
| Storage | Generally refrigerated at 2–8°C |
| Singapore address listed by brand | 16 Tai Seng Street, Level 4, Singapore 534138 |
| Associated group | Hyphens Pharma International Limited |
The brand’s official website describes VisioPro as a “clinically proven, high potency” probiotic, noting that its formulation has been the subject of numerous clinical studies and scientific publications.
History and Rebranding
VisioPro’s immediate history is closely linked to Vivomixx®. Prior to 2025, the probiotic formulation was marketed in Singapore under the Vivomixx name. Hyphens Pharma subsequently transitioned the brand to VisioPro®. The company’s 2025 annual report confirms that VisioPro was rebranded from Vivomixx in March 2025, while retaining the same underlying formulation.
Hyphens Pharma disclosed that it acquired the Singapore trademark for Visiopro®, integrating the brand into its proprietary-brand portfolio 2. Consequently, the change represented primarily a brand-identity transition rather than the introduction of an entirely new probiotic formulation.
The De Simone Formulation
The central differentiating feature of VisioPro is the De Simone Formulation. According to the brand, this formulation was developed by Claudio De Simone, MD, PhD, a physician and professor specializing in infectious diseases and immunology. It consists of a fixed combination of eight bacterial strains selected for their individual characteristics and intended synergistic activity.
The eight strains listed by VisioPro are:
- Streptococcus thermophilus DSM 24731 / NCIMB 30438
- Bifidobacterium breve DSM 24732 / NCIMB 30441
- Bifidobacterium longum DSM 24736 / NCIMB 30435
- Bifidobacterium infantis DSM 24737 / NCIMB 30436
- Lactobacillus acidophilus DSM 24735 / NCIMB 30442
- Lactobacillus plantarum DSM 24730 / NCIMB 30437
- Lactobacillus paracasei DSM 24733 / NCIMB 30439
- Lactobacillus delbrueckii subsp. bulgaricus DSM 24734 / NCIMB 30440
VisioPro notes that some of these organisms have subsequently been reclassified taxonomically. For instance, B. longum and B. infantis strains are now classified as B. lactis, and L. delbrueckii subsp. bulgaricus is classified as L. helveticus.
Product Portfolio
VisioPro offers a portfolio of products rather than a single item.
VisioPro Capsule
The standard capsule product contains approximately 112.5 billion live bacteria per capsule. It is marketed for general digestive and gut health, utilizes the eight-strain formulation, and is available through pharmacy channels.
VisioPro Sachet
The sachet version contains approximately 450 billion live bacteria per sachet. It is designed to be mixed into water, yogurt, or another suitable cold, non-carbonated drink 3.
VisioPro Kids
The children’s range includes a lower-dose sachet format designed for younger users. The Singapore product list specifies a 10-billion sachet product for children.
VisioPro Women
VisioPro markets a women’s formulation in sachet form, listed at 225 billion live bacteria per sachet, with positioning focused on gut and women’s health.
VisioPro Plus
The Plus product is another high-potency sachet option, listed at 225 billion live bacteria per sachet.
VisioPro Drops
The brand also offers probiotic drops in a 10 ml format, extending the portfolio to infant and young-child applications.
Potency
High bacterial concentration is a primary marketing characteristic of VisioPro. The brand lists the following potencies:
- 112.5 billion live bacteria per capsule
- 450 billion live bacteria per standard sachet
- 225 billion live bacteria per Plus/Women sachet
- 10 billion per Kids sachet
These figures refer to the quantity of live bacterial organisms supplied by the respective product at the stated potency. This high-potency positioning distinguishes VisioPro from many conventional probiotic supplements that contain substantially smaller quantities of microorganisms.
Storage and Cold Chain
Because VisioPro contains live bacteria, temperature control is critical for product handling. The brand recommends storage at 2–8°C. It states that products can generally be kept at room temperature up to 25°C for up to one week without affecting potency, though prolonged exposure to higher temperatures should be avoided.
This requirement influences distribution logistics; Singapore retailers describe VisioPro as a refrigerated product and utilize cold-chain delivery for certain items.
Ingredients and Characteristics
According to the Singapore brand website, VisioPro products are:
- Gluten-free
- Soy-free
- Non-GMO
- Free of preservatives
- Free of synthetic sweeteners in the capsule formulation
- Free of artificial colouring agents
The product may contain traces of milk derivatives, a distinction relevant for consumers with milk allergies or sensitivities.
Scientific Positioning
VisioPro’s principal scientific proposition relies on its use of the De Simone Formulation. The brand’s website states that the formulation has been investigated in more than 80 clinical studies and more than 200 scientific publications. Hyphens Pharma’s 2025 annual report corroborates these figures, describing the formulation as supported by over 80 clinical studies and 200 scientific publications.
It is important to distinguish evidence concerning the specific formulation from evidence concerning probiotics in general; a clinical study of the De Simone Formulation does not automatically imply that every probiotic product yields the same effects.
Intended Role
VisioPro is positioned as a food supplement rather than a replacement for a balanced diet or medical treatment. The brand describes its purpose as helping maintain or restore intestinal microbiota balance and supporting digestive well-being. Its website discusses usage across different life stages, including children, adults, and seniors. For medical conditions, appropriate use depends on the individual and the specific condition; a supplement should not be regarded as a treatment for disease.
VisioPro in Singapore
Singapore appears to be a key market for the brand. The official Singapore website lists its contact address at 16 Tai Seng Street, Level 4, Singapore 534138.
The portfolio is divided into pharmacy-range and clinic-range products. The pharmacy range includes the standard capsule and Kids products, while the clinic range includes higher-potency sachets and specialized products. The brand is also sold through online channels in Singapore.
Corporate Relationship
VisioPro should not be confused with a standalone pharmaceutical manufacturer despite being presented as a healthcare brand. In Singapore, Hyphens Pharma International Limited is the corporate group associated with the brand. Hyphens is a Singapore-listed healthcare company whose portfolio spans pharmaceuticals, medical aesthetics, proprietary healthcare brands, and digital healthcare services. Its 2025 reporting specifically identifies VisioPro as part of its proprietary-brand portfolio.
Brand Positioning Summary
VisioPro’s brand proposition can be summarized as: High-potency, multi-strain probiotics based on the De Simone Formulation, positioned around scientifically supported gut and microbiota health.
Its main differentiators include:
- Eight-strain formulation
- Very high bacterial counts
- Use of the De Simone Formulation
- Scientific/clinical positioning
- Products tailored for different age and demographic groups
- Refrigerated/cold-chain handling requirements
- Continuity from the established Vivomixx product identity
Comparison: VisioPro vs. Vivomixx
| Aspect | Vivomixx | VisioPro |
|---|---|---|
| Brand status in Singapore | Previous branding | Current branding |
| Relationship | Original market identity | Rebranded identity |
| Formulation | De Simone Formulation | De Simone Formulation |
| Main focus | Gut health | Gut health |
| Rebrand period | — | March 2025 |
| Corporate connection | Hyphens distribution/portfolio history | Hyphens proprietary brand |
| Product concept | High-potency multi-strain probiotic | High-potency multi-strain probiotic |
Hyphens explicitly states that VisioPro was previously marketed as Vivomixx and that the rebranding retained the same trusted formulation 3.





